Recent Comments
Archived Facts

ZURICH (Reuters) – Swiss drugmaker Roche has ended efforts to develop a heart disease drug that according to some industry analysts could have achieved $ 10 billion annual sales, after poor results from a late stage trial.

Popular Posts:

Incoming search terms:

Related Posts:

Leave a Reply